Chikungunya is the exotic-sounding name of an emergent, mosquito-borne tropical viral infection that can cause chronic and debilitating joint pain and arthritis. It’s also the first target of an exciting new approach that injects genetic material into the bodies of infected and at-risk individuals to trigger rapid production of potent, virus-neutralizing antibodies.